Medicine guide

NULOJIX

As listed in the register: NULOJIX 250 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

250 mg belatacept · polvo para concentrado para solución para perfusión

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Belatacept
Made by
Bristol-Myers Squibb Pharma Eeig

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupCancer treatments and immune-system medicinesL04AA28

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byBristol-Myers Squibb Pharma Eeig
Active substanceBelatacept
Used inCancer treatments and immune-system medicines
Strength250 mg belatacept
Formpolvo para concentrado para solución para perfusión
ClassificationL04AA28 · Cancer treatments and immune-system medicines
Routevía intravenosa
MarketedYes, according to the register
Name in the registerNULOJIX 250 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Nº Registro11694002

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.